Anzeige
Erschienen in:
01.01.2005 | Brief Report
Dexamethasone decreases neurological sequelae and caspase activity
Erschienen in: Intensive Care Medicine | Ausgabe 1/2005
Einloggen, um Zugang zu erhaltenAbstract
Objective
To evaluate the use of dexamethasone in a model of meningitis-induced brain injury. Changes in neurobehavioral performance were the primary outcome variables. Changes in caspase activation and markers of neuronal injury were the secondary outcome variables.
Design
Randomized, prospective animal study.
Setting
University research laboratory.
Subjects
Male Wistar rats.
Interventions
Animals underwent a basilar cistern injection of either placebo or a suspension of Group B Streptococcus. Sixteen hours after inoculation, animals were randomized and received either dexamethasone or placebo in addition to antibiotics. Neurobehavioral performance and biological markers of brain injury were assessed at 3 days and 9 days after randomization. In a second experiment, caspase 1 and 3 were evaluated at 6 h, 24 h, and 72 h after dexamethasone administration.
Measurements and main results
Neurobehavioral performance at 3 days and 9 days was significantly improved in the dexamethasone group. Serum C-tau and cerebral edema were decreased after 3 days of dexamethasone treatment. Dexamethasone decreased Caspase 3 activation in meningitic animals.
Conclusion
These findings demonstrate that dexamethasone decreases acute brain injury in a rat model of bacterial meningitis as measured by preservation of neurobehavioral performance.